Barriers to Receiving Tissue Plasminogen Activator in Patients with Ischemic Stroke
Background: Cerebrovascular diseases are the second common cause of mortality worldwide. The onset of reperfusion in the first 3-4.5 hours is a predictive factor of treatment. Objective: The present study investigated barriers to receiving tissue plasminogen activator in patients with ischemic strok...
Saved in:
Published in | Majallah-i dānishgāh-i ʻulūm-i pizishkī-i Qazvīn Vol. 25; no. 1; pp. 11 - 18 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English Persian |
Published |
Qazvin University of Medical Sciences & Health Services
01.04.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background: Cerebrovascular diseases are the second common cause of mortality worldwide. The onset of reperfusion in the first 3-4.5 hours is a predictive factor of treatment. Objective: The present study investigated barriers to receiving tissue plasminogen activator in patients with ischemic stroke. Methods: This cross-sectional study examined 191 patients with first-ever stroke referring to the emergency department of the Persian Gulf Martyrs Hospital of Bushehr City, Iran, in 2016. One checklist was completed which included demographic data, history of diseases, knowledge of stroke symptoms, and intervals regarding the onset of symptoms to informing emergency, informing emergency on arrival at the emergency department of the hospital, and making the diagnosis for the patients. The obtained data were analyzed in SPSS v. 19. Results: Mean±SD age of the patients was 65.92±12.48 years. The majority of patients under investigation (55.5%) were female, 63.4% were married, 56% were illiterate and 72.3% resided in other districts of Bushehr province. Mean duration between onset of symptoms and arrival at emergency department, onset of symptoms and call the emergency service, time of arrival at emergency department to perform brain Computer Tomography (CT) scan and also to be counseled by a neurologist were 699.66, 195.51, 45.11 and 423.62 minutes, respectively. Finally 14.6 percent of patients were qualified to be treated with tPA. Conclusion: The main barrier to timely therapy is a delay in golden time. Therefore, public education to promote public awareness could be of great benefit in reducing the referral delay time. |
---|---|
AbstractList | Background: Cerebrovascular diseases are the second common cause of mortality worldwide. The onset of reperfusion in the first 3-4.5 hours is a predictive factor of treatment. Objective: The present study investigated barriers to receiving tissue plasminogen activator in patients with ischemic stroke. Methods: This cross-sectional study examined 191 patients with first-ever stroke referring to the emergency department of the Persian Gulf Martyrs Hospital of Bushehr City, Iran, in 2016. One checklist was completed which included demographic data, history of diseases, knowledge of stroke symptoms, and intervals regarding the onset of symptoms to informing emergency, informing emergency on arrival at the emergency department of the hospital, and making the diagnosis for the patients. The obtained data were analyzed in SPSS v. 19. Results: Mean±SD age of the patients was 65.92±12.48 years. The majority of patients under investigation (55.5%) were female, 63.4% were married, 56% were illiterate and 72.3% resided in other districts of Bushehr province. Mean duration between onset of symptoms and arrival at emergency department, onset of symptoms and call the emergency service, time of arrival at emergency department to perform brain Computer Tomography (CT) scan and also to be counseled by a neurologist were 699.66, 195.51, 45.11 and 423.62 minutes, respectively. Finally 14.6 percent of patients were qualified to be treated with tPA. Conclusion: The main barrier to timely therapy is a delay in golden time. Therefore, public education to promote public awareness could be of great benefit in reducing the referral delay time. |
Author | Mirzadeh, Monirsadat Motamed, Niloofar Emami, Ali Mozhdehipanah, Hossein |
Author_xml | – sequence: 1 givenname: Monirsadat surname: Mirzadeh fullname: Mirzadeh, Monirsadat – sequence: 2 givenname: Hossein surname: Mozhdehipanah fullname: Mozhdehipanah, Hossein – sequence: 3 givenname: Ali surname: Emami fullname: Emami, Ali – sequence: 4 givenname: Niloofar surname: Motamed fullname: Motamed, Niloofar |
BookMark | eNpNkFtLAzEUhIMoWGsffc8f2HVz28tjLV4qFautz-FscrZNbTeSrBX_vUsr4tMMw_DBzAU5bX2LhFyxLBVcVeX148vb0yLlKmUpPyEDLrlIVMnk6T9_TkYxbrIsY4XIciYGZHEDITgMkXaevqJBt3ftii5djJ9I51uIO9f6FbZ0bDq3h84H6lo6h85h20X65bo1nUazxp0zdNEF_46X5KyBbcTRrw7J8u52OXlIZs_308l4lhgmBU8wM1aUOStVJVVtG2QCZWNzpSzUpQGlCoONySsmbZ9XrG9UwGuVmRpzLoZkesRaDxv9EdwOwrf24PQh8GGlIXTObFFDP9kCIgdTSl40Nedg68IUApTstWclR5YJPsaAzR-PZfrwrz78q7nSTHPxA9SAcVs |
ContentType | Journal Article |
CorporateAuthor | Metabolic Diseases Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran Persian Gulf Nuclear Medicine Research Center, The Persian Gulf Biomedical Research Center, Bushehr University of Medical Sciences, Bushehr, Iran Department of Neurology, Bou-Ali Sina Hospital, Qazvin University of Medical Sciences, Qazvin, Iran Student Research Committee, Qazvin University of Medical Sciences, Qazvin, Iran |
CorporateAuthor_xml | – name: Persian Gulf Nuclear Medicine Research Center, The Persian Gulf Biomedical Research Center, Bushehr University of Medical Sciences, Bushehr, Iran – name: Metabolic Diseases Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran – name: Student Research Committee, Qazvin University of Medical Sciences, Qazvin, Iran – name: Department of Neurology, Bou-Ali Sina Hospital, Qazvin University of Medical Sciences, Qazvin, Iran |
DBID | AAYXX CITATION DOA |
DOI | 10.32598/JQUMS.25.1.2 |
DatabaseName | CrossRef DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2423-5814 2228-7213 |
EndPage | 18 |
ExternalDocumentID | oai_doaj_org_article_a000daee2ac8427fb22adb7c73a54b7c 10_32598_JQUMS_25_1_2 |
GroupedDBID | AAYXX ADBBV ALMA_UNASSIGNED_HOLDINGS BCNDV CITATION GROUPED_DOAJ KQ8 5VS |
ID | FETCH-LOGICAL-c1432-e0cd386185945bdfe13e4fd655dab8ca557cefc6914d4fd91fe19a2b50cbe623 |
IEDL.DBID | DOA |
ISSN | 2423-5814 1561-3666 |
IngestDate | Wed Aug 27 01:31:28 EDT 2025 Tue Jul 01 00:34:51 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 1 |
Language | English Persian |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c1432-e0cd386185945bdfe13e4fd655dab8ca557cefc6914d4fd91fe19a2b50cbe623 |
OpenAccessLink | https://doaj.org/article/a000daee2ac8427fb22adb7c73a54b7c |
PageCount | 8 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_a000daee2ac8427fb22adb7c73a54b7c crossref_primary_10_32598_JQUMS_25_1_2 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-04-01 |
PublicationDateYYYYMMDD | 2021-04-01 |
PublicationDate_xml | – month: 04 year: 2021 text: 2021-04-01 day: 01 |
PublicationDecade | 2020 |
PublicationTitle | Majallah-i dānishgāh-i ʻulūm-i pizishkī-i Qazvīn |
PublicationYear | 2021 |
Publisher | Qazvin University of Medical Sciences & Health Services |
Publisher_xml | – name: Qazvin University of Medical Sciences & Health Services |
SSID | ssj0001730613 ssib026971087 |
Score | 2.1406682 |
Snippet | Background: Cerebrovascular diseases are the second common cause of mortality worldwide. The onset of reperfusion in the first 3-4.5 hours is a predictive... |
SourceID | doaj crossref |
SourceType | Open Website Index Database |
StartPage | 11 |
SubjectTerms | health services accessibility stroke therapeutics time |
Title | Barriers to Receiving Tissue Plasminogen Activator in Patients with Ischemic Stroke |
URI | https://doaj.org/article/a000daee2ac8427fb22adb7c73a54b7c |
Volume | 25 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LSwMxEA7iyYsoKtYXOYi3bZvXZvfYiqUWKpW20FvIE4q4K-36_51kq9STF0-BEJbwzSTzTZj9BqF7IqNEjNeZsEFm3MsAZ06YTBaO2pxRzWn8d3j6ko-XfLISq71WX7EmrJUHboHraTizTntPtS04lcFQqp2RVjItOIzx9oWYt5dMgSfRvITImbrjQX5CMgYkvRXYZED3i97kdTmdd6noQob4KyDt6fanADM6Qcc7ZogH7Y5O0UHQZ2g-1JvYU26LmxoDxfPr-ACAFwkuPAPq-76uanACPLCpUVm9wesKz1q11C2Oz6z4GTLYWAOP582mfvPnaDF6WjyOs10fhMwCm6GZ71vHihwia8mFccET5nlwuRBOm8JqIaT1weYl4Q7mSwIrSk2N6Fvjgd5coMOqrvwlwsznATiXh5ul4IxT43hJPKdOEhGAmHTQwzcW6qNVu1CQJSTQVAJNUaGIoh00jEj9LIoi1WkCTKd2plN_me7qPz5yjY5oLDNJxTQ36LDZfPpb4AmNuUsu8QXX0rv3 |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Barriers+to+Receiving+Tissue+Plasminogen+Activator+in+Patients+with+Ischemic+Stroke&rft.jtitle=Majallah-i+d%C4%81nishg%C4%81h-i+%CA%BBul%C5%ABm-i+pizishk%C4%AB-i+Qazv%C4%ABn&rft.au=Mirzadeh%2C+Monirsadat&rft.au=Mozhdehipanah%2C+Hossein&rft.au=Emami%2C+Ali&rft.au=Motamed%2C+Niloofar&rft.date=2021-04-01&rft.issn=2423-5814&rft.eissn=2423-5814&rft.volume=25&rft.issue=1&rft.spage=11&rft.epage=18&rft_id=info:doi/10.32598%2FJQUMS.25.1.2&rft.externalDBID=n%2Fa&rft.externalDocID=10_32598_JQUMS_25_1_2 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2423-5814&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2423-5814&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2423-5814&client=summon |